Dynamic contrast-enhanced MRI diagnostics in oncology via principal component analysis

Journal of Chemometrics

Volumn 22, Issue 11-12, 2008, Pages 708-716

  Bruwer, Mark John ^a   MacGregor, John F ^a   Noseworthy, Michael D ^b,c  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

DCE MRI; Latent variable modeling (LVM); Multivariate image analysis (MIA); Oncology; PCA

Indexed keywords

DIAGNOSIS; IMAGE ANALYSIS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE; MAGNETIC RESONANCE IMAGING; MULTIVARIANT ANALYSIS; PRINCIPAL COMPONENT ANALYSIS;

DYNAMIC CONTRAST ENHANCED MRI; DYNAMIC CONTRAST-ENHANCED; DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGE; LATENT VARIABLE MODELING; MODEL-BASED OPC; MULTIVARIATE IMAGE ANALYSE; MULTIVARIATE IMAGE ANALYSIS; PHARMACOKINETIC MODELING; PRINCIPAL-COMPONENT ANALYSIS;

ONCOLOGY;

EID: 57149114960     PISSN: 08869383     EISSN: 1099128X     Source Type: Journal    
DOI: 10.1002/cem.1143     Document Type: Conference Paper

References (27)

1. Jackson A, Buckley DL, Parker GJM (eds). Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Oncology. Springer-Verlag: Berlin, Germany, 2005.
2. Gribbestad IS, Gjesdal KI, Nilsen G, Lundgren S, Hjelstuen MHB, Jackson A. An introduction to dynamic contrast-enhanced MRI in oncology. In Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Oncology, Jackson A, Buckley DL, Parker GJM (eds.). Springer-Verlag: Berlin, Germany, 2005; 3-22.
3. Padhani AR. Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J. Magn. Reson. Imaging 2002; 16(4): 407-422.
4. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J. Magn. Reson. Imaging 1997; 7: 91-101.
5. Noseworthy MD, Ackerley C, Qi X, Wright GA. Correlating subcellular contrast agent location from dynamic contrast-enhanced magnetic resonance imaging (dMRI) and analytical electron microscopy. Acad. Radiol. 2002; 9(2): S514-S518.
6. Buckley DL. Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI. Magn. Reson. Med. 2002; 47(3): 601-606.
7. Henderson E, Sykes J, Drost D, Weinmann H-J, Rutt BK, Lee TY. Simultaneous MRI measurement of blood flow, blood volume, and capillary permeability in mammary tumors using two different contrast agents. J. Magn. Reson. Imaging 2000; 12(6): 991-1003.
8. Nomikos P, MacGregor JF. Monitoring batch processes using multiway principal component analysis. AIChE J. 1994; 40(8): 1361-1375.
9. Kourti T. Application of latent variable methods to process control and multivariate statistical process control in industry. Int. J. Adapt. Control Signal Process. 2005; 19: 213-246.
10. Wold S, Esbensen K, Geladi P. Principal component analysis. Chemometr. Intell. Lab. Syst. 1987; 2: 37-52.
11. Geladi P, Grahn H. Multivariate Image Analysis. John Wiley & Sons: Chichester, UK, 1996.
12. Twellmann T, Saalbach A, Gerstung O, Leach MO, Nattkemper TW. Image fusion for dynamic contrast enhanced magnetic resonance imaging. BioMedical Engineering OnLine 2004; 3(35).
13. Noseworthy MD, Morton G, Wright GA. Dynamic MR imaging for assessment of prostate carcinoma. In ISMRM Workshop on MR in Experimental and Clinical Cancer Research. International Society for Magnetic Resonance in Medicine: St. Louis, MO, USA, 1998; 110.
14. Noseworthy MD, Morton G, Wright GA. Comparison of normal and cancerous prostate using dynamic T1 and T2* weighted MRI. In Proceedings of the International Society of Magnetic Resonance in Medicine, Vol. 7, 1999; 1102.
15. Rifkin MD, Piccoli CW. Male pelvis and bladder. In Magnetic Resonance Imaging, Jackson A, Buckley DL, Parker GJM (eds.). CV Mosby: Toronto, 1992; 2022-2057.
16. Padhani AR. Dynamic contrast-enhanced MRI of prostate cancer. In Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Oncology, Stark DD, Bradley WG Jnr. (eds.). Springer-Verlag: Berlin, Germany, 2005; 191-213.
17. Eriksson L, Johansson E, Kettaneh-Wold N, Wold S. Multi- and Megavariate Data Analysis: Principles and Applications. Umetrics Academy: Tvistevägen 48, Box 7960, SE-907 19, Umeå, Sweden, 2001.
18. Noworolski SM, Henry RG, Vigneron DB, Kurhanewicz J. Dynamic contrast-enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI. Magn. Reson. Med. 2005; 53: 249-255.
19. Bharati MH, MacGregor JF. Multivariate image analysis for real-time process monitoring and control. Ind. Eng. Chem. Res. 1998; 37: 4715-4724.
20. Buckley DL, Roberts C, Parker GJM, Logue JP, Hutchinson CE. Prostate cancer: evaluation of vascular characteristics with dynamic contrastenhanced T1-weighted MR imaging - initial experience. Radiology 2004; 233: 709-715.
21. Engelbrecht MR, Huisman HJ, Laheij RJF, Jager GJ, van Leenders GJLH, De Kaa CAH-V, de la Rosette JJMCH, Blickman JG, Barentsz JO. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR Imaging. Radiology 2003; 229: 248-254.
22. Padhani AR, Gapinski CJ, MacVicar DA, Parker GJ, Suckling J, Revell PB, Leach MO, Dearnaley DP, Husband JE. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin. Radiol. 2000; 55(2): 99-109.
23. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, Larsson HB, Lee T-Y, Mayr NA, Parker GJ, Port RE, Taylor J, Weisskoff RM. Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusable tracer: standardized quantities and symbols. J. Magn. Reson. Imaging 1999; 10(3): 223-232.
24. Tofts PS, Berkowitz B, Schnall MD. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeabilitymodel. Magn. Reson. Med. 1995; 33(4): 564-568.
25. Kiessling F, Lichy M, Grobholz R, Heilmann M, Farhan N, Michel MS, Trojan L, Ederle J, Abel U, Kauczor H-U, Semmler W, Delorme S. Simple models improve the discrimination of prostate cancers from the peripheral gland by T1-weighted dynamic MRI. Eur. Radiol. 2004; 14: 1793-1801.
26. Rijpkema M, Kaanders JHAM, Joosten FBM, van der Kogel AJ, Heerschap A. Method for quantitative mapping of dynamic MRI contrast agent uptake inhumantumors. J. Magn. Reson. Imaging 2001; 14: 457-463.
27. Henderson E, Rutt BK, Lee T-Y. Temporal sampling requirements for the tracer kinetics modeling of breast disease. Magn. Reson. Imaging 1998; 16(9): 1057-1073.